Nuveen
XBI icon

Nuveen’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Nuveen’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-149,658
Closed -$12.1M – 3424
2025
Q1 		$12.1M Buy
149,658
+542
+0.4% +$48.4K ﹤0.01% 1434
2024
Q4 		$13.4M Buy
149,116
+39
+0% +$3.78K ﹤0.01% 1433
2024
Q3 		$14.7M Buy
149,077
+1,182
+0.8% +$116K ﹤0.01% 1380
2024
Q2 		$13.7M Sell
147,895
-58,005
-28% -$5.2M ﹤0.01% 1375
2024
Q1 		$19.5M Sell
205,900
-269
-0.1% -$25K 0.01% 1198
2023
Q4 		$18.4M Buy
206,169
+18,630
+10% +$1.38M 0.01% 1214
2023
Q3 		$13.7M Buy
187,539
+62
+0% +$4.95K ﹤0.01% 1286
2023
Q2 		$15.6M Sell
187,477
-132
-0.1% -$11K 0.01% 1243
2023
Q1 		$14.3M Buy
187,609
+34,817
+23% +$2.89M 0.01% 1256
2022
Q4 		$12.7M Buy
152,792
+99,163
+185% +$8.03M ﹤0.01% 1338
2022
Q3 		$4.25M Buy
+53,629
New +$4.52M ﹤0.01% 1995
2020
Q4 		– Sell
-39,006
Closed -$4.35M – 3372
2020
Q3 		$4.35M Sell
39,006
-8,903
-19% -$998K ﹤0.01% 1987
2020
Q2 		$5.36M Sell
47,909
-20,487
-30% -$2.02M ﹤0.01% 1856
2020
Q1 		$5.3M Buy
68,396
+39,253
+135% +$3.48M ﹤0.01% 1687
2019
Q4 		$2.77M Sell
29,143
-15,884
-35% -$1.37M ﹤0.01% 2287
2019
Q3 		$3.43M Sell
45,027
-29,284
-39% -$2.43M ﹤0.01% 2147
2019
Q2 		$6.52M Buy
74,311
+25,697
+53% +$2.19M ﹤0.01% 1845
2019
Q1 		$4.4M Buy
48,614
+21,470
+79% +$1.83M 0.02% 528
2018
Q4 		$1.95M Sell
27,144
-123,215
-82% -$9.93M 0.01% 622
2018
Q3 		$14.4M Buy
150,359
+2,674
+2% +$259K 0.08% 372
2018
Q2 		$14.1M Sell
147,685
-599
-0.4% -$55.1K 0.09% 328
2018
Q1 		$13M Buy
148,284
+18,069
+14% +$1.65M 0.08% 331
2017
Q4 		$11.1M Sell
130,215
-5,343
-4% -$448K 0.07% 370
2017
Q3 		$11.7M Buy
135,558
+13,961
+11% +$1.12M 0.08% 361
2017
Q2 		$9.38M Buy
+121,597
New +$8.62M 0.06% 422

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Nuveen's XBI Position: Q2 2025 in Review

Nuveen sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 149,658 shares — an estimated $12.1M sold.

Nuveen first reported a position in XBI in Q2 2017 and held it in 25 quarters. The position peaked at $19.5M in Q1 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

  • Nuveen reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 149,658 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $12.1M.
  • Nuveen first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and held it in 25 quarters.
  • Nuveen's State Street SPDR S&P Biotech ETF position peaked at $19.5M in Q1 2024.
  • 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.